tirzepatide 15mg pen MOUNJARO 15 MG / 0.5 ML ( ) FOR SUBCUTANEOUS INJECTION 4 PRE-FILLED PENS Mounjaro® KwikPen® 15mg (1 Pen)

GLP-1s arent ready to be used to address any psychiatric condition

Addressing neurodegeneration in glaucoma: mechanisms, challenges, and treatments

The objective was to evaluate the effectiveness and safety, with a specific focus on cardiovascular safety, of tirzepatide, a novel dual GIP and GLP-1 receptor agonist, compared to insulin glargine in adults with type 2 diabetes and a high risk of cardiovascular events who have not achieved adequate control with oral glucose-lowering medications.This phase 3 study was conducted at 187 sites across 14 countries on five continents

That heavy blanket of tiredness that just wont lift, even after a good nights sleep

Chun IK, Lee YH, Lee KE, Gwak HS